OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
COTRP Corts Trust for JC Penney Debentures
PVL Permianville Royalty Trust
BEST BEST Inc
FUPBY Fuchs Petrolub SE
JACK Jack in the Box Inc
NH NantHealth Inc
PWSC PowerSchool Holdings Inc
AEHL Antelope Enterprise Holdings Ltd
POR Portland General Electric Co
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) develops, manufactures, and distributes of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions. OraSure's segments consist of Diagnostics and Molecular Solutions. Diagnostics business segment primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products. The Diagnostics business includes tests for diseases including COVID-19, human immunodeficiency virus (HIV) and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Molecular Solutions business products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Price
Delayed
$4.00
Day's Change
-0.005 (-0.12%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.09
Day's Low
3.96
Volume
(Below Average)

Today's volume of 476,159 shares is on pace to be lower than OSUR's 10-day average volume of 877,195 shares.

476,159

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

11:53 am ET August 2, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NASDAQ:OSUR), EQNX::TICKER_END OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Tuesday, August 9, 2022.

August 9, 2022 schedule:

4:05 p.m. ET - 2022 second quarter financial results press release will be distributed.

4:50 p.m. ET - To participate in the conference call, dial (866) 374-5140 and reference conference ID #11565698.

5:00 p.m. ET - Conference call and simultaneous webcast begins.

The conference call will also be available via webcast, and may be accessed on the investor relations page of OraSure's website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access, 10 minutes prior to the call.

If you are unable to participate, a replay of the call will be archived on OraSure's website shortly after the call has ended and will be available for 14 days.

Investor Contact:                                           Media Contact:
Scott Gleason                                               Amy Koch
Interim CFO & SVP Investor Relations & Corp. Communications Sr. Mgr. Corporate Communications
484-425-0588                                                484-523-1815
sgleason@orasure.com                                        media@orasure.com

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

comtex tracking

COMTEX_411429057/2010/2022-08-02T11:53:17

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.